{"entity":{"type":"insider","cik":"0001250274","url":"/insider/0001250274","json_url":"/insider/0001250274.json","name":"ISRAEL ROBERT J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":89,"n_filings":69,"first":"2004-03-03","last":"2015-06-15","span_basis":"filed_date"},"name_variants":[{"name":"ISRAEL ROBERT J","source":"filing","n_filings":69,"first_seen":"2004-03-03","last_seen":"2015-06-15"}],"transactions":[{"id":8891245,"accession":"0001447348-15-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-15-000036","line_url":"/filing/0001447348-15-000036#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":13660.0,"total_display":"13,660.00","total_whole":"13,660","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-15","scope":"insider"},{"id":8258916,"accession":"0001447348-15-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-15-000020","line_url":"/filing/0001447348-15-000020#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":21000.0,"total_display":"21,000.00","total_whole":"21,000","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-16","scope":"insider"},{"id":8471142,"accession":"0001447348-15-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-15-000018","line_url":"/filing/0001447348-15-000018#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":13660.0,"total_display":"13,660.00","total_whole":"13,660","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-13","scope":"insider"},{"id":8622988,"accession":"0001447348-15-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-15-000016","line_url":"/filing/0001447348-15-000016#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.49,"price_display":"6.49","price_state":"stated","total_value":32450.0,"total_display":"32,450.00","total_whole":"32,450","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-03","filed_date":"2015-03-04","scope":"insider"},{"id":8221421,"accession":"0001447348-15-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-15-000002","line_url":"/filing/0001447348-15-000002#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":7.056,"price_display":"7.06","price_state":"stated","total_value":14112.0,"total_display":"14,112.00","total_whole":"14,112","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-13","scope":"insider"},{"id":6623609,"accession":"0001447348-14-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-14-000036","line_url":"/filing/0001447348-14-000036#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.067,"price_display":"7.07","price_state":"stated","total_value":21201.0,"total_display":"21,201.00","total_whole":"21,201","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-12","scope":"insider"},{"id":6194415,"accession":"0001447348-14-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-14-000034","line_url":"/filing/0001447348-14-000034#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":63000.0,"total_display":"63,000.00","total_whole":"63,000","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-21","scope":"insider"},{"id":6351662,"accession":"0001447348-14-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-14-000032","line_url":"/filing/0001447348-14-000032#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":68300.0,"total_display":"68,300.00","total_whole":"68,300","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-14","scope":"insider"},{"id":6687076,"accession":"0001447348-14-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-14-000030","line_url":"/filing/0001447348-14-000030#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Executive Vice President, Medi)","role_mark":"O","role_mark_label":"Officer (Executive Vice President, Medi)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President, Medi","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.53,"price_display":"6.53","price_state":"stated","total_value":32650.0,"total_display":"32,650.00","total_whole":"32,650","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-12","scope":"insider"},{"id":5401393,"accession":"0001447348-13-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-13-000031","line_url":"/filing/0001447348-13-000031#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":31650.0,"total_display":"31,650.00","total_whole":"31,650","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-18","filed_date":"2013-07-22","scope":"insider"},{"id":3352082,"accession":"0001447348-12-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000040","line_url":"/filing/0001447348-12-000040#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.79,"price_display":"9.79","price_state":"stated","total_value":9790.0,"total_display":"9,790.00","total_whole":"9,790","shares_owned_after":35050.0,"shares_owned_after_display":"35,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-02","filed_date":"2012-07-03","scope":"insider"},{"id":2932924,"accession":"0001447348-12-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000028","line_url":"/filing/0001447348-12-000028#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.508,"price_display":"8.51","price_state":"stated","total_value":8508.0,"total_display":"8,508.00","total_whole":"8,508","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-01","filed_date":"2012-06-04","scope":"insider"},{"id":2314513,"accession":"0001447348-12-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000025","line_url":"/filing/0001447348-12-000025#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":10.927,"price_display":"10.93","price_state":"stated","total_value":10927.0,"total_display":"10,927.00","total_whole":"10,927","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-01","filed_date":"2012-05-03","scope":"insider"},{"id":3033602,"accession":"0001447348-12-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000022","line_url":"/filing/0001447348-12-000022#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.852,"price_display":"9.85","price_state":"stated","total_value":9852.0,"total_display":"9,852.00","total_whole":"9,852","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-02","filed_date":"2012-04-03","scope":"insider"},{"id":3548388,"accession":"0001447348-12-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000013","line_url":"/filing/0001447348-12-000013#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.817,"price_display":"9.82","price_state":"stated","total_value":9817.0,"total_display":"9,817.00","total_whole":"9,817","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-02","scope":"insider"},{"id":3403366,"accession":"0001447348-12-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000005","line_url":"/filing/0001447348-12-000005#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.478,"price_display":"9.48","price_state":"stated","total_value":9478.0,"total_display":"9,478.00","total_whole":"9,478","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-02","scope":"insider"},{"id":3318138,"accession":"0001447348-12-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000002","line_url":"/filing/0001447348-12-000002#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.78,"price_display":"8.78","price_state":"stated","total_value":8780.0,"total_display":"8,780.00","total_whole":"8,780","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":9155081,"accession":"0001447348-11-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-11-000020","line_url":"/filing/0001447348-11-000020#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.66,"price_display":"6.66","price_state":"stated","total_value":6660.0,"total_display":"6,660.00","total_whole":"6,660","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-02","scope":"insider"},{"id":9125285,"accession":"0001447348-11-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-11-000017","line_url":"/filing/0001447348-11-000017#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":6330.0,"total_display":"6,330.00","total_whole":"6,330","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-01","scope":"insider"},{"id":8951160,"accession":"0001447348-11-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-11-000015","line_url":"/filing/0001447348-11-000015#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":6330.0,"total_display":"6,330.00","total_whole":"6,330","shares_owned_after":38383.0,"shares_owned_after_display":"38,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-05","filed_date":"2011-10-05","scope":"insider"},{"id":8933411,"accession":"0001447348-11-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-11-000011","line_url":"/filing/0001447348-11-000011#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":746.0,"shares_display":"746","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":4722.18,"total_display":"4,722.18","total_whole":"4,722","shares_owned_after":37843.0,"shares_owned_after_display":"37,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-27","filed_date":"2011-09-28","scope":"insider"},{"id":9029146,"accession":"0001447348-11-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-11-000009","line_url":"/filing/0001447348-11-000009#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":633.0,"total_display":"633.00","total_whole":"633","shares_owned_after":37843.0,"shares_owned_after_display":"37,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-20","filed_date":"2011-09-21","scope":"insider"},{"id":8826963,"accession":"0001266375-11-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-11-000006","line_url":"/filing/0001266375-11-000006#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154.0,"shares_display":"154","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":974.82,"total_display":"974.82","total_whole":"975","shares_owned_after":37843.0,"shares_owned_after_display":"37,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-06","scope":"insider"},{"id":8826960,"accession":"0001266375-11-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-11-000004","line_url":"/filing/0001266375-11-000004#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":6330.0,"total_display":"6,330.00","total_whole":"6,330","shares_owned_after":37843.0,"shares_owned_after_display":"37,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-12","scope":"insider"},{"id":9005570,"accession":"0001441844-11-000028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001441844-11-000028","line_url":"/filing/0001441844-11-000028#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":7.205,"price_display":"7.20","price_state":"stated","total_value":7205.0,"total_display":"7,205.00","total_whole":"7,205","shares_owned_after":36151.0,"shares_owned_after_display":"36,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-01","filed_date":"2011-07-06","scope":"insider"},{"id":9000050,"accession":"0001441844-11-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-11-000025","line_url":"/filing/0001441844-11-000025#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7889.0,"shares_display":"7,889","price_per_share":7.015,"price_display":"7.02","price_state":"stated","total_value":55341.335,"total_display":"55,341.34","total_whole":"55,341","shares_owned_after":36151.0,"shares_owned_after_display":"36,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-21","filed_date":"2011-06-22","scope":"insider"},{"id":9094569,"accession":"0001441844-11-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-11-000020","line_url":"/filing/0001441844-11-000020#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Senior VP Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Senior VP Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.153,"price_display":"8.15","price_state":"stated","total_value":8153.0,"total_display":"8,153.00","total_whole":"8,153","shares_owned_after":44040.0,"shares_owned_after_display":"44,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-01","filed_date":"2011-06-02","scope":"insider"},{"id":9018102,"accession":"0001441844-11-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-11-000018","line_url":"/filing/0001441844-11-000018#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":7.39,"price_display":"7.39","price_state":"stated","total_value":7390.0,"total_display":"7,390.00","total_whole":"7,390","shares_owned_after":44040.0,"shares_owned_after_display":"44,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-02","filed_date":"2011-05-04","scope":"insider"},{"id":8871167,"accession":"0001441844-11-000013","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001441844-11-000013","line_url":"/filing/0001441844-11-000013#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":6330.0,"total_display":"6,330.00","total_whole":"6,330","shares_owned_after":43377.0,"shares_owned_after_display":"43,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-05","scope":"insider"},{"id":9057952,"accession":"0001441844-11-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-11-000012","line_url":"/filing/0001441844-11-000012#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":5064.0,"total_display":"5,064.00","total_whole":"5,064","shares_owned_after":43377.0,"shares_owned_after_display":"43,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-29","filed_date":"2011-03-30","scope":"insider"},{"id":9184814,"accession":"0001441844-11-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-11-000008","line_url":"/filing/0001441844-11-000008#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":1266.0,"total_display":"1,266.00","total_whole":"1,266","shares_owned_after":43377.0,"shares_owned_after_display":"43,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-09","scope":"insider"},{"id":9125275,"accession":"0001441844-11-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-11-000006","line_url":"/filing/0001441844-11-000006#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7597.0,"shares_display":"7,597","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":48089.01,"total_display":"48,089.01","total_whole":"48,089","shares_owned_after":43377.0,"shares_owned_after_display":"43,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-07","filed_date":"2011-02-08","scope":"insider"},{"id":8980300,"accession":"0001441844-11-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-11-000005","line_url":"/filing/0001441844-11-000005#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":403.0,"shares_display":"403","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":2550.99,"total_display":"2,550.99","total_whole":"2,551","shares_owned_after":43377.0,"shares_owned_after_display":"43,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-19","filed_date":"2011-01-20","scope":"insider"},{"id":7373982,"accession":"0001441844-10-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000039","line_url":"/filing/0001441844-10-000039#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6180.0,"shares_display":"6,180","price_per_share":5.819,"price_display":"5.82","price_state":"stated","total_value":35961.42,"total_display":"35,961.42","total_whole":"35,961","shares_owned_after":31186.0,"shares_owned_after_display":"31,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-22","filed_date":"2010-06-24","scope":"insider"},{"id":7554658,"accession":"0001441844-10-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000015","line_url":"/filing/0001441844-10-000015#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7056.0,"shares_display":"7,056","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":37890.72,"total_display":"37,890.72","total_whole":"37,891","shares_owned_after":36842.0,"shares_owned_after_display":"36,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-18","filed_date":"2010-03-18","scope":"insider"},{"id":3468530,"accession":"0001441844-08-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-08-000005","line_url":"/filing/0001441844-08-000005#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":39801.0,"shares_owned_after_display":"39,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-03","filed_date":"2008-09-04","scope":"insider"},{"id":3603518,"accession":"0001441844-08-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-08-000002","line_url":"/filing/0001441844-08-000002#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.465,"price_display":"16.46","price_state":"stated","total_value":16465.0,"total_display":"16,465.00","total_whole":"16,465","shares_owned_after":39801.0,"shares_owned_after_display":"39,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-05","scope":"insider"},{"id":3779812,"accession":"0001432664-08-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001432664-08-000003","line_url":"/filing/0001432664-08-000003#line-5","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.592,"price_display":"15.59","price_state":"stated","total_value":15592.0,"total_display":"15,592.00","total_whole":"15,592","shares_owned_after":33134.0,"shares_owned_after_display":"33,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-01","filed_date":"2008-07-03","scope":"insider"},{"id":3381008,"accession":"0001266375-08-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-08-000024","line_url":"/filing/0001266375-08-000024#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.397,"price_display":"16.40","price_state":"stated","total_value":16397.0,"total_display":"16,397.00","total_whole":"16,397","shares_owned_after":36291.0,"shares_owned_after_display":"36,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-02","scope":"insider"},{"id":3990208,"accession":"0001266375-08-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-08-000023","line_url":"/filing/0001266375-08-000023#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":36291.0,"shares_owned_after_display":"36,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-27","filed_date":"2008-05-28","scope":"insider"},{"id":3630374,"accession":"0001266375-08-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-08-000020","line_url":"/filing/0001266375-08-000020#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":36291.0,"shares_owned_after_display":"36,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-25","filed_date":"2008-04-28","scope":"insider"},{"id":4034404,"accession":"0001266375-08-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-08-000011","line_url":"/filing/0001266375-08-000011#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":15300.0,"total_display":"15,300.00","total_whole":"15,300","shares_owned_after":35879.0,"shares_owned_after_display":"35,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3598817,"accession":"0001266375-08-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-08-000010","line_url":"/filing/0001266375-08-000010#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.44,"price_display":"16.44","price_state":"stated","total_value":16440.0,"total_display":"16,440.00","total_whole":"16,440","shares_owned_after":35879.0,"shares_owned_after_display":"35,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-01","filed_date":"2008-02-04","scope":"insider"},{"id":2912012,"accession":"0001266375-08-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-08-000006","line_url":"/filing/0001266375-08-000006#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":18.12,"price_display":"18.12","price_state":"stated","total_value":18120.0,"total_display":"18,120.00","total_whole":"18,120","shares_owned_after":35879.0,"shares_owned_after_display":"35,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-02","filed_date":"2008-01-04","scope":"insider"},{"id":6996830,"accession":"0001266375-07-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000080","line_url":"/filing/0001266375-07-000080#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","total_whole":"20,000","shares_owned_after":35730.0,"shares_owned_after_display":"35,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-10","scope":"insider"},{"id":7755616,"accession":"0001266375-07-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000079","line_url":"/filing/0001266375-07-000079#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":19.239,"price_display":"19.24","price_state":"stated","total_value":19239.0,"total_display":"19,239.00","total_whole":"19,239","shares_owned_after":35730.0,"shares_owned_after_display":"35,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-03","filed_date":"2007-12-05","scope":"insider"},{"id":5496213,"accession":"0001266375-06-000111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000111","line_url":"/filing/0001266375-06-000111#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":26690.0,"shares_owned_after_display":"26,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-04","filed_date":"2006-12-06","scope":"insider"},{"id":4031552,"accession":"0001266375-06-000110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000110","line_url":"/filing/0001266375-06-000110#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":26.913,"price_display":"26.91","price_state":"stated","total_value":134565.0,"total_display":"134,565.00","total_whole":"134,565","shares_owned_after":26690.0,"shares_owned_after_display":"26,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-01","filed_date":"2006-12-05","scope":"insider"},{"id":3140219,"accession":"0001266375-06-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000103","line_url":"/filing/0001266375-06-000103#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":26690.0,"shares_owned_after_display":"26,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-10","filed_date":"2006-11-14","scope":"insider"},{"id":4461430,"accession":"0001266375-06-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000101","line_url":"/filing/0001266375-06-000101#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250274","owner_name":"ISRAEL ROBERT J","owner_display_name":"ISRAEL ROBERT J","owner_url":"/insider/0001250274","role":"Officer (Sr. VP, Medical Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Medical Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.964,"price_display":"25.96","price_state":"stated","total_value":129820.0,"total_display":"129,820.00","total_whole":"129,820","shares_owned_after":26690.0,"shares_owned_after_display":"26,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-01","filed_date":"2006-11-02","scope":"insider"}],"collapsed":true,"next_cursor":"2006-11-01|4461430","ledger_fault":false,"count":{"value":89,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":89,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":89},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Officer (Executive Vice President, Medi)","n_filings":69,"first_seen":"2004-03-03","last_seen":"2015-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001250274","retrieved_at":"2026-08-25T18:41:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}